Inhibiting Toll-like Receptor 2 Reduces Age-Related Pancreatic Islet Inflammation and Fibrosis
Genetic and pharmacological inhibition of Toll-like receptor 2 reduces age-associated immune cell infiltration and fibrotic remodeling in mouse pancreatic islets.


